Article Details
Retrieved on: 2021-05-11 20:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Achieved $60 million milestone from Roche for first patient dosed in Phase 2b PADOVA study of prasinezumab in patients with early Parkinson's ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here